健之佳：股东王雁萍累计质押145万股

Group 1 - The core point of the article is that Jianzhijia (SH 605266) announced a pledge extension of shares by its major shareholder Wang Yanping, who holds approximately 15.46 million shares, accounting for 10.01% of the total share capital [1] - After the pledge extension, Wang Yanping has pledged a total of 1.45 million shares, which is 9.38% of her holdings and 0.94% of the company's total shares [1] - For the first half of 2025, Jianzhijia's revenue composition is as follows: 90.17% from pharmaceutical retail and services, 5.51% from other businesses, 4.17% from convenience retail, and 0.15% from pharmaceutical wholesale [1] Group 2 - As of the report, Jianzhijia has a market capitalization of 3.3 billion yuan [2] - The Chinese innovative drug sector has seen significant overseas licensing sales, totaling 80 billion USD this year, indicating a hot secondary market in biomedicine [2]